Catalog No.: PC-62895Not For Human Use, Lab Use Only.
Fasentin is a novel inhibitor of glucose uptake (GLUT) that sensitizes cancer cells to FAS-induced cell death, preferentially inhibits GLUT4 (IC50=68 uM) over GLUT1.
Fasentin is a novel inhibitor of glucose uptake (GLUT) that sensitizes cancer cells to FAS-induced cell death, preferentially inhibits GLUT4 (IC50=68 uM) over GLUT1.
Fasentin sensitizes cancer cells to the death ligands FAS and TNF apoptosis-inducing ligand, and induces G1 cell cycle arrest.
